Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease

被引:8
|
作者
Liu, Xi [1 ]
Shen, Ling [1 ]
Han, Bing [1 ]
Yao, Honghong [1 ]
机构
[1] Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China
来源
NON-CODING RNA RESEARCH | 2021年 / 6卷 / 03期
关键词
Noncoding RNA; Blood-brain barrier; Central nervous system disease; INTRINSIC ANTIVIRAL IMMUNITY; TUMOR BARRIER; TIGHT JUNCTIONS; INTRACEREBRAL HEMORRHAGE; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; PERMEABILITY; EXPRESSION; DISRUPTION; INJURY;
D O I
10.1016/j.ncrna.2021.06.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Given the important role of the blood-brain barrier (BBB) in the central nervous system (CNS), increasing studies have been carried out to determine how the structural and functional integrity of the BBB impacts the pathogenesis of CNS diseases such as stroke, traumatic brain injuries (TBIs), and gliomas. Emerging studies have revealed that noncoding RNAs (ncRNAs) help to maintain the integrity and permeability of the BBB, thereby mediating CNS homeostasis. This review summarizes recent studies that focus on the effects of ncRNAs on the BBB in CNS diseases, including regulating the biological processes of inflammation, necrosis, and apoptosis of cells, affecting the translational dysfunction of proteins and regulating tight junctions (TJs). A comprehensive and detailed understanding of the interaction between ncRNAs and the BBB will lay a solid foundation for the development of early diagnostic methods and effective treatments for CNS diseases.
引用
收藏
页码:130 / 138
页数:9
相关论文
共 50 条
  • [41] Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
    Alavijeh M.S.
    Chishty M.
    Qaiser M.Z.
    Palmer A.M.
    NeuroRX, 2005, 2 (4): : 554 - 571
  • [42] Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Galor, Anat
    Ference, Sandra J.
    Singh, Arun D.
    Lee, Michael S.
    Stevens, Glen H. J.
    Perez, Victor L.
    Peereboom, David M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (01) : 45 - 49
  • [43] Examining the Uptake of Central Nervous System Drugs and Candidates across the Blood-Brain Barrier
    Summerfield, Scott G.
    Zhang, Yanyan
    Liu, Houfu
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 358 (02): : 294 - 305
  • [44] Complement activation in the central nervous system following blood-brain barrier damage in man
    Lindsberg, PJ
    Ohman, J
    Lehto, T
    KarjalainenLindsberg, ML
    Paetau, A
    Wuorimaa, T
    Carpen, O
    Kaste, M
    Meri, S
    ANNALS OF NEUROLOGY, 1996, 40 (04) : 587 - 596
  • [45] Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Goldstein, Debra A.
    Tessler, Howard H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (06) : 976 - 976
  • [46] Pathways for Small Molecule Delivery to the Central Nervous System Across the Blood-Brain Barrier
    Mikitsh, John L.
    Chacko, Ann-Marie
    PERSPECTIVES IN MEDICINAL CHEMISTRY, 2014, 6 : 11 - 24
  • [47] Matrix metalloproteinases cause blood-brain barrier disruption in central nervous system tuberculosis
    Brilha, Sara
    Ong, Catherine W. M.
    Friedland, Jon S.
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 27 - 27
  • [48] Pathways Exploited by Flaviviruses to Counteract the Blood-Brain Barrier and Invade the Central Nervous System
    Mustafa, Yasmin Mucuna
    Meuren, Lana Monteiro
    Antunes Coelho, Sharton Vinicius
    de Arruda, Luciana Barros
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [49] Complement and blood-brain barrier integrity
    Alexander, J.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 17 - 17
  • [50] Targeted Analysis of Central Nervous System Using Blood-Brain Barrier Shuttle Peptides
    Huang Yan-Yan
    Zhao Rui
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2019, 47 (10) : 1629 - 1638